Immuron(IMRN) - 2022 Q4 - Earnings Call Presentation

y n o e s u l a n o s r e p r o F 11 Immuron INVESTOR PRESENTATION FY22 RESULTS & BUSINESS UPDATE 31 AUGUST, 2022 Steven Lydeamore - CEO NASDAQ: IMRN ASX: IMC EXECUTIVE SUMMARY y n o e s u l a n o s r e p r o F 22 Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a globally integrated biopharmaceutical company focused on developing, and commercialising, oral immunotherapeutics for the treatment of gut mediated diseases | --- | --- | --- | |--------------------|-------------|-------------------------------------------- ...